Header cover image

German Biotech Breakthroughs

Results

1

0 new

Biotech stocks worldwide which are expected to become profitable in the next 3 years.

1 companies

Formycon

Market Cap: €392.9m

A biotechnology company, develops biosimilar drugs in Germany and Switzerland.

FYB

€22.25

7D

-2.8%

1Y

-47.2%